We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Radware
RDWR
$1.19B
| $1.1M | ﹤0.01% |
50,527
-166,990
| -77% | -$3.72M |
|
2677
Energy Vault
NRGV
$633M
| $1.1M | ﹤0.01% |
208,403
+57,396
| +38% | +$312K |
|
2678
Oppenheimer Holdings
OPY
$1.2B
| $1.1M | ﹤0.01% |
35,530
-616
| -2% | -$21.6K |
|
2679
Shore Bancshares
SHBI
$796M
| $1.1M | ﹤0.01% |
63,510
-197
| -0.3% | -$3.74K |
|
2680
Edgewise Therapeutics
EWTX
$4.73B
| $1.1M | ﹤0.01% |
111,609
-2,728
| -2% | -$27.6K |
|
2681
Lindblad Expeditions
LIND
$2.22B
| $1.1M | ﹤0.01% |
162,458
+24,333
| +18% | +$212K |
|
|
DHC
2682
Diversified Healthcare Trust
DHC
$2.14B
| $1.1M | ﹤0.01% |
1,106,734
+236,114
| +27% | +$378K |
|
|
CORZ
2683
DELISTED
Core Scientific, Inc. Common Stock
CORZ
| $1.09M | ﹤0.01% |
840,898
+75,593
| +10% | +$161K |
|
2684
Farmers & Merchants Bancorp
FMAO
$481M
| $1.09M | ﹤0.01% |
40,439
-88
| -0.2% | -$2.62K |
|
2685
MasterCraft Boat Holdings
MCFT
$590M
| $1.09M | ﹤0.01% |
57,648
+92
| +0.2% | +$2.12K |
|
2686
Teekay
TK
$985M
| $1.08M | ﹤0.01% |
302,369
-22,741
| -7% | -$75.6K |
|
2687
Babcock & Wilcox
BW
$1.39B
| $1.08M | ﹤0.01% |
169,794
+176
| +0.1% | +$1.31K |
|
2688
Monte Rosa Therapeutics
GLUE
$1.35B
| $1.08M | ﹤0.01% |
132,647
-2,128
| -2% | -$19.5K |
|
2689
South Plains Financial
SPFI
$841M
| $1.08M | ﹤0.01% |
39,194
-2,922
| -7% | -$76.2K |
|
2690
Tiptree Inc
TIPT
$675M
| $1.08M | ﹤0.01% |
100,142
-13,256
| -12% | -$151K |
|
|
HLGN
2691
DELISTED
Heliogen, Inc.
HLGN
| $1.08M | ﹤0.01% |
16,566
+15,798
| +2,057% | +$1.23M |
|
2692
Ocular Therapeutix
OCUL
$2.02B
| $1.07M | ﹤0.01% |
257,262
-90,835
| -26% | -$458K |
|
2693
Flex
FLEX
$44.8B
| $1.07M | ﹤0.01% |
84,888
-78,835
| -48% | -$1.01M |
|
|
PLYA
2694
DELISTED
Playa Hotels & Resorts
PLYA
| $1.06M | ﹤0.01% |
182,878
+157,623
| +624% | +$1.04M |
|
|
AMNB
2695
DELISTED
American National Bankshares Inc
AMNB
| $1.06M | ﹤0.01% |
33,304
-1,176
| -3% | -$40.2K |
|
|
GOEV
2696
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $1.06M | ﹤0.01% |
1,231
+73
| +6% | +$106K |
|
2697
Enviri
NVRI
$620M
| $1.06M | ﹤0.01% |
283,674
-3,507
| -1% | -$19.4K |
|
|
TDAY
2698
USA Today Co
TDAY
$1.06B
| $1.06M | ﹤0.01% |
692,354
+32,305
| +5% | +$78.4K |
|
|
PETQ
2699
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.06M | ﹤0.01% |
153,475
-30,938
| -17% | -$417K |
|
2700
Pennant Group
PNTG
$1.36B
| $1.05M | ﹤0.01% |
101,142
-630
| -0.6% | -$9K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.